|
| KPT-330, (E)-RN Basic information |
Product Name: | KPT-330, (E)-RN | Synonyms: | (E)-3-(3-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-1H-1,2,4-TRIAZOL-1-YL)-N'-(PYRAZIN-2-YL)ACRYLOHYDRAZIDE;KPT-330, (E)-RN;KPT-330, (E)-RN (E)-3-(3-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-1H-1,2,4-TRIAZOL-1-YL)-N'-(PYRAZIN-2-YL)ACRYLOHYDRAZIDE;(E)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N'-pyrazin-2-ylprop-2-enehydrazide;SELINEXOR;KPT-330; (E)-RN;Kpt-330, (E)-;Selinexor E-isomer;Selinexor trans-isomer | CAS: | 1421923-86-5 | MF: | C17H11F6N7O | MW: | 443.31 | EINECS: | | Product Categories: | Inhibitors | Mol File: | 1421923-86-5.mol | |
| KPT-330, (E)-RN Chemical Properties |
density | 1.55±0.1 g/cm3(Predicted) | pka | 9.74±0.43(Predicted) |
| KPT-330, (E)-RN Usage And Synthesis |
Uses | KPT-330 is an orally bioavailable selective?Chromosome Region Maintenance (CRM1)?inhibitor, that has been shown to block pancreatic cancer cell proliferation and reduce tumor growth in mice. |
| KPT-330, (E)-RN Preparation Products And Raw materials |
|